Your patient is on long-term prednisone therapy. This patient should have frequent follow-up office visits to assess for which of the following?
Dermatitis and headaches
Heart failure and headaches
Hyperglycemia and osteoporosis
Weight loss and hypoglycemia
The Correct Answer is C
A. Dermatitis and headaches: Prednisone use can sometimes cause skin issues, but dermatitis is not a common side effect. Headaches can also occur, but they are not specific to long-term prednisone therapy.
B. Heart failure and headaches: Prednisone does not directly cause heart failure. Headaches can occur but are not specific indicators of prednisone side effects.
C. Hyperglycemia and osteoporosis: Prednisone can lead to elevated blood glucose levels (hyperglycemia) and increased bone loss (osteoporosis) when used long-term. Regular monitoring is essential to manage these potential side effects.
D. Weight loss and hypoglycemia: Prednisone can cause weight gain rather than weight loss. Hypoglycemia (low blood sugar) is not a common side effect of prednisone; it typically causes hyperglycemia (high blood sugar) instead.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
Vancomycin is often administered over at least 60 minutes to reduce the risk of infusion-related reactions, such as "Red Man Syndrome," which is characterized by flushing, rash, and itching. This reaction is caused by the rapid infusion of vancomycin, leading to the release of histamine.
Correct Answer is A
Explanation
A. Ceftaroline (Teflaro) is a fifth-generation cephalosporin antibiotic that is effective against MRSA (Methicillin-Resistant Staphylococcus Aureus). It's the first cephalosporin in its class with this capability, making it a valuable choice in treating MRSA infections.
B. Cefepime (Maxipime) is a fourth-generation cephalosporin that does not have specific activity against MRSA.
C. Ceftriaxone (Rocephin) is a third-generation cephalosporin, effective against a wide range of bacteria, but not specifically targeted at MRSA.
D. Cephalexin (Keflex) is a first-generation cephalosporin, primarily effective against Gram-positive bacteria, but not effective against MRSA.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise, our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.